Dr. Christopher James Deline, MD

Dr. Deline practices at Cleveland Clinic Indian River Hospital in Vero Beach, Florida, part of The Cleveland Clinic Foundation.

Dr. Deline's NPI, 1740338060, was assigned on January 5, 2007. Dr. Deline graduated from Ross University School of Medicine in 2005. Dr. Deline holds New York license 270644.

Dr. Deline's primary practice is Cleveland Clinic Indian River Hospital, at 1000 36th St, Vero Beach, FL 32960 in Indian River County. The practice phone is (772) 567-4311.

Dr. Deline's primary practice is Cleveland Clinic Indian River Hospital in Vero Beach, Florida, part of The Cleveland Clinic Foundation. Dr. Deline is also affiliated with Buffalo General Medical Center/Gates Vascular Institute. The medical group on file is Cleveland Clinic Indian River Hospital. Dmand AI also links Dr. Deline to 1 more hospital and 3 medical groups, each named with a free account.

Dmand AI tracks the electronic health record (EHR) system at each site where Dr. Deline practices, 3 sites in all. Vendor and product names are available with a free account.

Vascular neurology is Dr. Deline's primary specialty in the NPI Registry, under taxonomy code 2084V0102X. Dr. Deline is board certified in neurology by the American Board of Psychiatry and Neurology. Dmand AI has Dr. Deline's licenses on file in 4 states: New York, Florida, Missouri and Wisconsin.

Dmand AI lists encephalopathy among the conditions Dr. Deline treats.

CMS data shows 243 Medicare services from Dr. Deline across 6 procedure codes in 2024, for 155 Medicare patients. Medicare paid $22,051 for them. Every service was in a facility, such as a hospital, rather than an office.

CMS counts 155 Medicare patients who saw Dr. Deline in 2024. The largest group is 65 to 74, with 56 patients. 75% of them have high blood pressure, and 75% have high cholesterol. 52% are also on Medicaid. Their average risk score is 2.15, where 1.00 is the Medicare average, so they are sicker than most Medicare patients.

Across all payers, Dmand AI patient panel data puts Dr. Deline's median patient age at 71, with 54% women.

In 2024, Dr. Deline wrote 125 Medicare Part D claims for 46 patients. 92% of them were for generic drugs. CMS names the drug for 67 of them, across 3 drugs with 11 or more claims each, at $542 in total drug cost. In 2021, CMS named 198 claims across 8 drugs.

CMS publishes a Merit-based Incentive Payment System (MIPS) score of 97 out of 100 for Dr. Deline for performance year 2024, reported through an alternative payment model (APM). Dr. Deline accepts Medicare assignment, so Medicare's approved amount is taken as full payment.

Dmand AI links 2 papers to Dr. Deline in 2017. 2017 was the busiest year, with 2. The most frequent topics are Administration, Intravenous, Brain Ischemia and Fibrinolytic Agents. Dr. Deline's most frequent co-authors are Ashkan Mowla, MD, Jordan Paul Doyle, MD and Haris Kamal, MD.

CMS Open Payments shows 15 general payments to Dr. Deline from 3 drug and device companies from 2016 to 2024. Food and beverage make up the largest share, 100% of the total. Medtronic Vascular, Inc. paid the most, $487.

Dr. Deline graduated from Ross University School of Medicine in 2005.

Dr. Deline is in network with 14 carriers, including Elevance, Aetna and Excellus BlueCross BlueShield. PPO plans come from the most carriers, 10. Check the plan with the practice before a visit.